For research use only. Not for therapeutic Use.
CycLuc1 is a synthetic luciferin analogue used primarily in bioluminescence imaging (BLI) applications. It is designed to enhance the sensitivity and stability of bioluminescent signals in biological systems, particularly in live cell and in vivo imaging studies. CycLuc1 offers several advantages over native luciferin, including increased light output and prolonged signal duration, which allow for more accurate and prolonged monitoring of biological processes. This compound is particularly valuable in preclinical research for tracking gene expression, monitoring disease progression, and evaluating the efficacy of therapeutic interventions. CycLuc1’s improved bioluminescent properties make it a critical tool in the advancement of molecular imaging technologies.
| Catalog Number | I012695 |
| CAS Number | 1247879-16-8 |
| Synonyms | (4S)-2-(6,7-dihydro-5H-pyrrolo[3,2-f][1,3]benzothiazol-2-yl)-4,5-dihydro-1,3-thiazole-4-carboxylic acid |
| Molecular Formula | C13H11N3O2S2 |
| Purity | ≥95% |
| IUPAC Name | (4S)-2-(6,7-dihydro-5H-pyrrolo[3,2-f][1,3]benzothiazol-2-yl)-4,5-dihydro-1,3-thiazole-4-carboxylic acid |
| InChI | InChI=1S/C13H11N3O2S2/c17-13(18)9-5-19-11(16-9)12-15-8-3-6-1-2-14-7(6)4-10(8)20-12/h3-4,9,14H,1-2,5H2,(H,17,18)/t9-/m1/s1 |
| InChIKey | HBZBAMXERPYTFS-SECBINFHSA-N |
| SMILES | C1CNC2=CC3=C(C=C21)N=C(S3)C4=NC(CS4)C(=O)O |
